Literature DB >> 9553674

Onycholysis in patients treated with docetaxel.

A Obermair, M Binder, M Barrada, D Bancher-Todesca, E Asseryanis, E Kubista.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9553674     DOI： 10.1023/a:1008218824342

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  4 in total

Review 1.  Dermatological adverse events with taxane chemotherapy.

Authors:  Vincent Sibaud; Nicole R Lebœuf; Henri Roche; Viswanath R Belum; Laurence Gladieff; Marion Deslandres; Marion Montastruc; Audrey Eche; Emmanuelle Vigarios; Florence Dalenc; Mario E Lacouture
Journal:  Eur J Dermatol       Date:  2016-10-01       Impact factor: 3.328

2.  Nail changes due to docetaxel--a neglected side effect and nuisance for the patient.

Authors:  Dorte Winther; Ditte Marie Saunte; Marianne Knap; Vera Haahr; Anders Bonde Jensen
Journal:  Support Care Cancer       Date:  2007-02-22       Impact factor: 3.603

3.  Docetaxel-induced nail changes--a neurogenic mechanism: a case report.

Authors:  Gunnar Wasner; Felix Hilpert; Jörn Schattschneider; Andreas Binder; Jacobus Pfisterer; Ralf Baron
Journal:  J Neurooncol       Date:  2002-06       Impact factor: 4.130

4.  Chemotherapy-induced dermatological toxicity: frequencies and impact on quality of life in women's cancers. Results of a prospective study.

Authors:  Mark Hackbarth; Norbert Haas; Christina Fotopoulou; Werner Lichtenegger; Jalid Sehouli
Journal:  Support Care Cancer       Date:  2007-08-07       Impact factor: 3.603
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.